Tetricus Labs
Healthcare Software · 1-10 Employees
View Company Info for Free
Overview
Website
www.tetricuslabs.comRevenue
<$5 MillionIndustry
About Tetricus Labs
Tetricus Labs, founded in 2022, focuses on integrating technology into psychiatric practice, enhancing the processes from diagnosis to treatment and recovery. The company develops software for psychiatric hospitals and independent providers, allowing them to access patient data with unprecedented detail. Their platform supports the comprehensive collection and analysis of a patient's digital phenotype, aiding both patients and clinicians in monitoring progress to optimize and personalize treatment. Tetricus Labs aims to empower patients to achieve better and faster outcomes in their mental health journey.Explore more
Tetricus Labs Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Tetricus Labs
Compare insights from companies similar to Tetricus Labs, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Tetricus Labs Tech Stack
A closer look at the technologies used by Tetricus Labs
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tetricus Labs
Sign Up For FreeTo access detailed company insights
Tetricus Labs, founded in 2022, focuses on integrating technology into psychiatric practice, enhancing the processes from diagnosis to treatment and recovery. The company develops software for psychiatric hospitals and independent providers, allowing them to access patient data with unprecedented detail. Their platform supports the comprehensive co... Read More
